Evidence map›Paper›PMID 23846691›Full record

ArticleThe Journal of biological chemistry2013

Inhibition of protein kinase C signaling maintains rat embryonic stem cell pluripotency.

Ganeshkumar Rajendran, Debasree Dutta, James Hong, Arindam Paul, Biswarup Saha, Biraj Mahato, Soma Ray, Pratik Home, Avishek Ganguly, Mark L Weiss and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Atypical protein kinase C iota (PKCλ/ι) ensures mammalian development by establishing the maternal-fetal exchange interface.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Article
  13. Deriving rabbit embryonic stem cells by small molecule inhibitors.American journal of translational research · 2019
    Article
  14. Article
  15. Article
  16. From engineering to editing the rat genome.Mammalian genome : official journal of the International Mammalian Genome Society · 2017
    Review
  17. Protein Kinase Cζ Inhibitor Promotes Resolution of Bleomycin-Induced Acute Lung Injury.American journal of respiratory cell and molecular biology · 2016
    Article
  18. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ganeshkumar RajendranInstitute for Reproductive Health and Regenerative Medicine, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Debasree Dutta
James Hong
Arindam Paul
Biswarup Saha
Biraj Mahato
Soma Ray
Pratik Home
Avishek Ganguly
Mark L Weiss
Soumen Paul
University of Kansas Medical Center · USKansas State University · USInstitute for Reproductive Health · US

Funding

GATA Factor Function in TrophoblastR01HD062546 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Soumen Paul, Geetu Tuteja · 2010 to 2026
$4.9M
Anti-angiogenic activity of neurokinin BR21HL094892 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PAUL, SOUMEN · 2009 to 2010
$413k
Protein Kinase C Signaling and Pluripotent Stem CellR21HL104322 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PAUL, SOUMEN · 2011 to 2012
$413k
Histone Chaperones in AngiogenesisR21HL106311 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PAUL, SOUMEN · 2011 to 2012
$413k
TEAD4 and Trophoblast LineageR21HD075233 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PAUL, SOUMEN · 2013 to 2014
$409k
NHLBI NIH HHS HL094892NHLBI NIH HHS HL106311NHLBI NIH HHS R21 HL094892NHLBI NIH HHS R21 HL104322NHLBI NIH HHS R21 HL106311NICHD NIH HHS HD062546NICHD NIH HHS R01 HD062546NICHD NIH HHS R21 HD075233PHS HHS L104322
6 · The paper itself

Abstract

Embryonic stem cell (ESC) pluripotency is orchestrated by distinct signaling pathways that are often targeted to maintain ESC self-renewal or their differentiation to other lineages. We showed earlier that inhibition of PKC signaling maintains pluripotency in mouse ESCs. Therefore, in this study, we investigated the importance of protein kinase C signaling in the context of rat ESC (rESC) pluripotency. Here we show that inhibition of PKC signaling is an efficient strategy to establish and maintain pluripotent rESCs and to facilitate reprogramming of rat embryonic fibroblasts to rat induced pluripotent stem cells. The complete developmental potential of rESCs was confirmed with viable chimeras and germ line transmission. Our molecular analyses indicated that inhibition of a PKCζ-NF-κB-microRNA-21/microRNA-29 regulatory axis contributes to the maintenance of rESC self-renewal. In addition, PKC inhibition maintains ESC-specific epigenetic modifications at the chromatin domains of pluripotency genes and, thereby, maintains their expression. Our results indicate a conserved function of PKC signaling in balancing self-renewal versus differentiation of both mouse and rat ESCs and indicate that targeting PKC signaling might be an efficient strategy to establish ESCs from other mammalian species.

Indexed as

AnimalsEmbryonic Stem CellsIndolesMaleimidesMicroRNAsNF-kappa BPluripotent Stem CellsProtein Kinase C-epsilonProtein Kinase InhibitorsRatsSignal Transduction2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimideIndolesMaleimidesMicroRNAsmirn21 microRNA, ratMIRN29 microRNA, ratNF-kappa BPrkce protein, ratProtein Kinase C-epsilonProtein Kinase InhibitorsChromatin ModificationEmbryonic Stem CellNF-κBPKCRat

Identifiers

PMID23846691
PMCPMC3750137
OpenAlexW2082206889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.